Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04191460 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer

Study acronym: GuidedbyLight
StatusCompleted
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date changed from estimate of Jul 1, 2025 to May 22, 2026 Trial completed · Final enrollment: 31 participants (planned 28) · Primary completion date changed from estimate of May 1, 2025 to May 16, 2025 · 1 morev8 Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 31 participants (planned 28)
    • Primary completion date changed from estimate of May 1, 2025 to May 16, 2025
    • Site details revised
  2. Primary completion date: Sep 1, 2024 to May 1, 2025 Completion date: Mar 1, 2025 to Jul 1, 2025v7 Show 1 more changeShow less
    • Completion date: Mar 1, 2025 to Jul 1, 2025
  3. Re-verified, no change to tracked fieldsv6
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jul 1, 2022 to Jul 12, 2022 · Site details revisedv5 Show 2 more changesShow less
    • Start date changed from estimate of Jul 1, 2022 to Jul 12, 2022
    • Site details revised
  5. Primary completion date: Dec 1, 2023 to Sep 1, 2024 Start date: Oct 1, 2021 to Jul 1, 2022 · Completion date: Dec 1, 2023 to Mar 1, 2025v4 Show 2 more changesShow less
    • Start date: Oct 1, 2021 to Jul 1, 2022
    • Completion date: Dec 1, 2023 to Mar 1, 2025
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jan 2020 to Oct 1, 2021 Enrollment target: 29 to 28 · Primary and study completion dates: Jan 2024 to Dec 1, 2023 · Eligibility criteria expanded, about 105 words · 1 morev3 Show 4 more changesShow less
    • Enrollment target: 29 to 28
    • Primary and study completion dates: Jan 2024 to Dec 1, 2023
    • Eligibility criteria expanded, about 105 words
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a two-staged clinical trial to investigate the feasibility of intraoperative Fluorescence Imaging (FLI) to adequately assess tumor margins in patients with oral cancer using cRGD-ZW800-1.
Trial Details
NCT Number NCT04191460
Lead Sponsor Erasmus Medical Center
Conditions Squamous Cell Carcinoma of the Head and Neck, Oral Cancer, Squamous Cell Carcinoma of the Oral Cavity
Enrollment 31 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov